2023
Journal articles
Quagliata, M; Papini, AM; Rovero, P Therapeutic applications of thymosin peptides: a patent landscape 2018-present. EXPERT OPINION ON THERAPEUTIC PATENT, 2023 DOI
Nuti,F; Larregola, M; Staśkiewicz, A; Retzl, B; Tomašević, N; Macchia, L; Street, M. E; Jewgiński, M; Lequin, O; Latajka, R; Rovero, P; Gruber, C W; Chorev, M; Papini A M Design, synthesis, conformational analysis, and biological activity of Cα1-to-Cα6 1,4- and 4,1-disubstituted 1H-[1,2,3]triazol-1-yl-bridged oxytocin analogues, JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2023, 38:1 DOI
Gallorini, R; Aquilia, S; Bello, C; Ciardelli, F; Pinna, M; Papini, A M; Rosi,L. Pyrolysis of spent rapeseed meal: a circular economy example for waste valorization. JOURNAL OF ANALYTICAL AND APPLIED PYROLYSIS 2023, 174, 106138, 1-9. DOI
Stincarelli, M A; Quagliata, M; Di Santo, A; Pacini, L; Real Fernandez, F; Arvia,R; Rinaldi, S; Papini, A M; Rovero, P; Giannecchini,S. SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein. VIRUS RESEARCH 2023, 334, 199170 DOI
Schrems, M; Kravchuk, A V; Niederacher, G; Exler, F; Bello, C; Becker, C F W . A Light Cleavable Auxiliary for Diselenide-Selenoester Ligations of Peptides and Proteins. CHEMISTRY-A EUROPEAN JOURNAL 2023, 29, e202301253 DOI
Quagliata, M; Stincarelli, M A; Papini, A M; Giannecchini, S; Rovero, P. Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme-2. ACS OMEGA 2023, 8, 22665-22672 DOI
Ledwoń,P; Goldeman, W; Hałdys, K; Jewgiński, M; Calamai, G; Rossowska, J; Papini, A M; Rovero, P; Latajkaa, R. Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 2023, 38(1), 2193676, 1-12. DOI
Pacini, L; D'Ercole, A; Papini, A M; Bani, D; Nistri, S; Rovero, P. Porcine Relaxin but Not Serelaxin Shows Residual Bioactivity after In Vitro Simulated Intestinal Digestion-Clues for the Development of New Relaxin Peptide Agonists Suitable for Oral Delivery. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023, 24(1), 48, 1-9. DOI
Bello, C, Pranzini, E, Piemontese, E, Schrems, M, Taddei, M L, Giovannelli, L, Schubert, M, Becker, C F W, Rovero, P, Papini, A M, Chemoenzymatic Synthesis of Glycopeptides to Explore the Role of Mucin 1 Glycosylation in Cell Adhesion CHEMBIOCHEM 2023, 24, e202200741. DOI
Real-Fernandez F, Errante F, Di Santo A, Papini AM, Rovero P. Therapeutic proteins immunogenicity: a peptide point of view. EXPLORATION OF DRUG SCIENCE 2023;1:377–87. DOI
Quagliata M, Nuti F, Real-Fernandez F, Kirilova Kirilova K, Santoro F, Carotenuto A, Papini AM, Rovero P. Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis. JOURNAL OF PEPTIDE SCIENCE 2023; 29(7):e3475. DOI
Strauss P, Nuti F, Quagliata M, Papini AM, Hurevich M. Accelerated solid-phase synthesis of glycopeptides containing multiple N-glycosylated sites. ORGANIC AND BIOMOLECULAR CHEMISTRY 2023 Feb 22;21(8):1674-1679. DOI
Quagliata, M.; Papini, A.M.; Rovero, P. Malaria Vaccines. EXPERT OPINION ON THERAPEUTIC PATENTS 2023; 33(3), 169-178 . DOI
Last update
24.10.2024